ARTICLE | Company News
Merz neurology news
October 11, 2010 7:00 AM UTC
Merz's U.S. subsidiary Merz Pharmaceuticals LLC launched Xeomin incobotulinumtoxinA in the U.S. to treat adults with cervical dystonia or blepharospasm in patients previously treated with Botox onab...